Kyowa Pharma to Face Biz Suspension Order over Manufacturing Flaws

March 23, 2022
Kyowa Pharmaceutical Industry is expected to be hit by a business suspension order as early as this month over manufacturing deviations from approved methods, which were found to constitute a violation of the Pharmaceuticals and Medical Devices (PMD) Law, Jiho...read more